NutraLife BioSciences, Inc. (NLBS)
OTCMKTS: NLBS · Delayed Price · USD
0.0001
0.00 (0.00%)
Mar 1, 2024, 1:00 AM EDT - Market closed
NutraLife BioSciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0.63 | 1.26 | 2.13 | 3.71 | 1.79 | 0.39 | 0.19 | 0.06 | 0.6 | Upgrade
|
| Revenue Growth (YoY) | - | -50.10% | -41.14% | -42.51% | 107.32% | 356.84% | 101.99% | 211.52% | -89.58% | 372.27% | Upgrade
|
| Cost of Revenue | 0 | 0.54 | 0.75 | 1.54 | 2.21 | 1.06 | 0.03 | 0.12 | 0.35 | 0.35 | Upgrade
|
| Gross Profit | 0 | 0.08 | 0.51 | 0.6 | 1.5 | 0.74 | 0.36 | 0.07 | -0.29 | 0.25 | Upgrade
|
| Selling, General & Admin | 0 | 4.44 | 2.48 | 3.99 | 3.41 | 20.95 | 1.36 | 1.69 | 1.29 | 2.22 | Upgrade
|
| Other Operating Expenses | 0 | 0.11 | -0 | 0.06 | -0.03 | 0 | 0.06 | 0.06 | 0.05 | 0.05 | Upgrade
|
| Operating Expenses | 0 | 4.56 | 2.48 | 3.99 | 3.41 | 21.02 | 1.42 | 1.74 | 1.34 | 2.27 | Upgrade
|
| Operating Income | 0 | -4.47 | -1.97 | -3.4 | -1.91 | -20.29 | -1.06 | -1.67 | -1.63 | -2.02 | Upgrade
|
| Interest Income | 0 | 1.85 | 0.92 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Expense | 0 | 1.85 | 0.01 | 0.01 | 0.13 | 3.34 | 0.47 | 0.43 | 0.45 | 0.07 | Upgrade
|
| Other Expense / Income | - | 1.35 | 1.82 | 0.61 | -0.13 | -3.34 | -0.47 | -0.43 | -0.45 | -0.07 | Upgrade
|
| Pretax Income | 0 | -5.83 | -2.89 | -4.01 | -2.07 | -23.63 | -1.53 | -2.1 | -2.08 | -2.08 | Upgrade
|
| Income Tax | 0 | 1.86 | 0.01 | 0.07 | 0.17 | 3.34 | 0.47 | 0.43 | 0.45 | 0.07 | Upgrade
|
| Net Income | 0 | -7.68 | -2.9 | -4.07 | -2.07 | -23.63 | -1.53 | -2.1 | -2.08 | -2.08 | Upgrade
|
| Shares Outstanding (Basic) | - | 165 | 146 | 113 | 87 | 72 | 34 | 23 | 22 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | - | 165 | 146 | 113 | 87 | 72 | 34 | 23 | 22 | 18 | Upgrade
|
| Shares Change | - | 12.43% | 29.18% | 29.72% | 21.59% | 113.18% | 46.48% | 5.75% | 18.09% | 22.47% | Upgrade
|
| EPS (Basic) | - | -0.05 | -0.02 | -0.04 | -0.02 | -0.33 | -0.05 | -0.09 | -0.10 | -0.11 | Upgrade
|
| EPS (Diluted) | - | -0.05 | -0.02 | -0.04 | -0.02 | -0.33 | -0.05 | -0.09 | -0.10 | -0.11 | Upgrade
|
| Free Cash Flow | 0 | -0.49 | -1.28 | -4.53 | -0.82 | -1.19 | -0.69 | -0.9 | -1.26 | -1.14 | Upgrade
|
| Free Cash Flow Per Share | - | -0.00 | -0.01 | -0.04 | -0.01 | -0.02 | -0.02 | -0.04 | -0.06 | -0.06 | Upgrade
|
| Gross Margin | - | 13.34% | 40.60% | 28.03% | 40.42% | 41.06% | 91.62% | 37.68% | -465.76% | 41.96% | Upgrade
|
| Operating Margin | - | -713.77% | -157.12% | -159.14% | -51.36% | -1133.39% | -271.39% | -860.82% | -2618.18% | -337.32% | Upgrade
|
| Profit Margin | - | -1226.14% | -231.15% | -190.91% | -55.90% | -1319.94% | -390.09% | -1083.03% | -3333.20% | -348.52% | Upgrade
|
| Free Cash Flow Margin | - | -77.78% | -102.27% | -212.26% | -21.99% | -66.43% | -175.44% | -461.66% | -2020.43% | -190.96% | Upgrade
|
| EBITDA | 0 | -4.14 | -2.48 | -3.77 | -1.87 | -20.21 | -1 | -1.61 | -1.58 | -1.97 | Upgrade
|
| EBITDA Margin | - | -660.65% | -197.68% | -176.65% | -50.51% | -1128.90% | -255.95% | -832.05% | -2533.94% | -329.73% | Upgrade
|
| Depreciation & Amortization | 0 | 0.33 | 0.39 | 0.23 | 0.07 | 0.08 | 0.06 | 0.06 | 0.05 | 0.05 | Upgrade
|
| EBIT | - | -4.47 | -2.88 | -4 | -1.94 | -20.29 | -1.06 | -1.67 | -1.63 | -2.02 | Upgrade
|
| EBIT Margin | - | -712.75% | -229.11% | -187.45% | -52.29% | -1133.28% | -271.39% | -860.82% | -2618.15% | -337.32% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.